Part number: MN-1237-G
Image is representative (may not be specific item).
Download: Instructions for use - hemaPEN [PDF]
Also see: Video - Instructional video for hemaPEN use
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
Collections: All, hemaPEN, hemaPEN (all), Instructions for use, Literature - All, Literature - Health, Microsampling, Sampling, Support Items
Category: ARTG, ARTG 280007, Australia, Australian Register of Therapeutic Goods, Blood, CE mark, Class I, Clinical, DBS, EU, FDA, Health, hemaPEN, Histology, IFU, IVD, Life, Microsampling, New Zealand, Pathology, Research, Sample collection, Sampling, Support, TGA, Therapeutic Goods Administration, UK, US FDA, US FDA D410490, USA
Type: Instructions for use
Download: Advanced precision microsampling for COVID-19 research [PDF]
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Download: Brochure - hemaPEN [PDF]
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Download: Brochure - hemaPEN (research use only) [PDF]
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Download: Brochure - hemaPEN (research use only) (Japanese) [PDF]
hemaPENは開発中でプロトタイプデバイスが研究、調査目的のみで供給可能です。このデバイスは医療または診断には使用できません。Class 1血液採取と補完デバイスとしてhemaPENの登録が2019年末に予定されています。
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product detailsPrivacy and security | Terms and conditions
© 2020 Trajan Scientific and Medical. Trajan Scientific Australia Pty Ltd